> What I don't quite understand is why they couldn't just create some joint venture with a Western pharma company and then supply a rebranded version of the mRNA vaccines to their population.
I get the impression that Western companies have become a bit wary of those "joint ventures," following incidents like the ARM / Softbank / ARM China saga.
I get the impression that Western companies have become a bit wary of those "joint ventures," following incidents like the ARM / Softbank / ARM China saga.
Moderna specifically refused to share their mRNA IP with China: https://archive.ph/hxWuT